Holen Sie sich die Stockscreener-App
41.53
1.91%
0.7279
Schlusskurs vom Vortag:
$40.80
Offen:
$41.34
24-Stunden-Volumen:
115.54K
Relative Volume:
0.18
Marktkapitalisierung:
$1.86B
Einnahmen:
$1.15B
Nettoeinkommen (Verlust:
$23.09M
KGV:
83.06
EPS:
0.5
Netto-Cashflow:
$89.18M
1W Leistung:
+0.51%
1M Leistung:
-10.95%
6M Leistung:
+25.54%
1J Leistung:
+11.20%
1-Tages-Spanne:
$40.99
$41.83
1-Wochen-Bereich:
$39.97
$42.60
52-Wochen-Spanne:
$22.66
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
41.52 | 1.83B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
185.73 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.05 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.70 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
82.25 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.57 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Omnicell, Inc. $OMCL Shares Sold by JPMorgan Chase & Co. - MarketBeat
Omnicell Stock Analysis: Strong Performance vs. Long-Term ConcernsNews and Statistics - IndexBox
OMCL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Omnicell, Inc. (OMCL) Stock Analysis: Strong Buy Ratings And Nearly 40% Upside Potential - DirectorsTalk Interviews
Vanguard Group Inc. Has $170.89 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Roubaix Capital LLC Purchases Shares of 76,383 Omnicell, Inc. $OMCL - MarketBeat
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Finviz
What is Zacks Research's Estimate for Omnicell Q1 Earnings? - MarketBeat
Dividend Watch: Whats the fair value of Omnicell Inc stockEarnings Overview Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Omnicell, Inc. (OMCL): A Bull Case Theory - Yahoo Finance
Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell (OMCL) Investors? - Sahm
OMCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is Zacks Research's Estimate for Omnicell Q3 Earnings? - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Decoding Omnicell Inc (OMCL): A Strategic SWOT Insight - GuruFocus
(OMCL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Omnicell, Inc. (OMCL) Investor Outlook: Examining a 45% Potential Upside Amid Healthcare Innovation - DirectorsTalk Interviews
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know - Finviz
Healthcare Inventory Management Market Hits New High | Major - openPR.com
Omnicell Inc (OMCL) Trading 3.26% Higher on Feb 20 - GuruFocus
Omnicell (OMCL) VP reports tax withholding and ESPP share purchase - Stock Titan
Hospital Robotics (Logistics and Pharmacy) Market to Reach USD - openPR.com
Does Omnicell’s Profit Squeeze Amid Higher Sales and 2026 Outlook Change The Bull Case For OMCL? - simplywall.st
Merger Talk: Is NewAmsterdam Pharma Company NVs ROIC above industry average2025 Technical Overview & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Omnicell, Inc. (NASDAQ:OMCL) Sees Large Drop in Short Interest - MarketBeat
Responsive Playbooks and the OMCL Inflection - Stock Traders Daily
Growth Report: How volatile is Omnicell Inc stock2025 Price Momentum & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Reasons to add Omnicell stock to your portfolio right now - MSN
Smart Medicine Compounding Robot Market Is Going to Boom | ARxIUM - openPR.com
Omnicell (OMCL) Is Down 19.0% After Profit Squeeze Despite Solid 2026 Revenue OutlookWhat's Changed - Yahoo Finance
Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues As Shares Take 26% Pounding - 富途牛牛
Why Investors Shouldn't Be Surprised By Omnicell, Inc.'s (NASDAQ:OMCL) 26% Share Price Plunge - simplywall.st
The Top 5 Analyst Questions From Omnicell's Q4 Earnings Call - Finviz
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call - Yahoo Finance
Omnicell (NASDAQ:OMCL) Cut to Strong Sell at Zacks Research - MarketBeat
Omnicell, Inc. (OMCL) Stock Analysis: Unpacking a Potential 57% Upside in Healthcare Automation - DirectorsTalk Interviews
Omnicell (OMCL) Q4 2025 Earnings Call Transcript - AOL.com
Omnicell: Solid Execution and Strategic Promise Offset by Near-Term Profitability Pressures and Premium Valuation (Hold Rating Maintained) - TipRanks
Omnicell, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OMCL) 2026-02-08 - Seeking Alpha
Omnicell upgraded at BofA on buying opportunity ahead of Q4 results - MSN
Omnicell (OMCL) Margin Squeeze To 0.2% Net Profit Tests Bullish Recovery Narratives - Sahm
Analysts Conflicted on These Healthcare Names: Cigna (CI), Hims & Hers Health (HIMS) and Omnicell (OMCL) - The Globe and Mail
Omnicell (NASDAQ:OMCL) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Omnicell Earnings Call: Growth Intact, Margins Under Strain - The Globe and Mail
Omnicell, Inc. (NASDAQ:OMCL) Q4 2025 Earnings Call Transcript - Insider Monkey
Omnicell (NASDAQ:OMCL) Stock Price Down 4.2% on Disappointing Earnings - MarketBeat
Analyst Jessica Tassan Lowers Omnicell (OMCL) Price Target to $4 - GuruFocus
Omnicell Q4 2025 Earnings: Stock Dives on Missed EPS, 2026 GuidanceNews and Statistics - IndexBox
Omnicell Stock Pre-Market (-15%) : Q4 EPS Miss & Weak 2026 Guidance - Trefis
Pharmacy Automation Systems Market Set for Explosive Growth - openPR.com
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook - Finviz
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):